Every health/care industry stakeholder will be in search of value in 2023, I explain in my latest post written on behalf of Medecision. In this essay, I forecast what’s ahead for hospitals, digital health innovators and investors, employers, pharma, and patients-as-consumers — all firmly focused on value in the new year.
“Inflation may make consumers and the healthcare system sicker,” Deloitte expects, signaling a sort of “unrest” for the healthcare ecosystem.
One of the most telling data points I include in my assessment of 2023 comes from GSR Ventures, which polled major health care investors on the now and future state of digital health funding.
This piece chart demonstrates that investors have value-based care on their minds, coupled with the consumerization of health care.
Read more on how (and why) we will all be value-minded consumers of health care in 2023 on the Medecision site.
Thank you 
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global pharmaceutical company.
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance.